Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2023 | Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial | ECLINICALMEDICINE |